Increased resistance to proteasome inhibitors in multiple myeloma mediated by cIAP2 - implications for a combinatorial treatment

Despite the introduction of new treatment options for multiple myeloma (MM), a majority of patients relapse due to the development of resistance. Unraveling new mechanisms underlying resistance could lead to identification of possible targets for combinatorial treatment. Using TRAF3 deleted/mutated...

Descripción completa

Detalles Bibliográficos
Autores principales: Duvefelt, Charlotte Fristedt, Lub, Susanne, Agarwal, Prasoon, Arngården, Linda, Hammarberg, Anna, Maes, Ken, Van Valckenborgh, Els, Vanderkerken, Karin, Wiklund, Helena Jernberg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653030/
https://www.ncbi.nlm.nih.gov/pubmed/26036313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653030/
https://www.ncbi.nlm.nih.gov/pubmed/26036313

Ejemplares similares